PRODUCT DETAILS

About Vilglipt-M 50/500 Tablet

METFORMIN+VILDAGLIPTIN is a combination drug of Vildagliptin (DPP-4 inhibitor), and Metformin (Biguanides) belongs to the class of anti-diabetic. Type 2 diabetes mellitus used to be known as 'non-insulin-dependent diabetes mellitus (NIDDM)' or 'maturity-onset diabetes'. Type 2 diabetes develops if the body does not produce enough insulin, or where the insulin that your body makes does not work as well as it should. It can also develop if the body produces too much glucagon. Insulin is a substance which helps to lower the level of sugar in your blood, especially after meals. METFORMIN+VILDAGLIPTIN is another substance which triggers the production of sugar by the liver, causing the blood sugar to rise. The pancreas makes both of these substances.

METFORMIN+VILDAGLIPTIN helps to control the blood sugar level. It works by making the pancreas produce insulin and less glucagon (effect of vildagliptin) and also by helping the body to make better use of the insulin it produces (effect of metformin)

Uses of Vilglipt-M 50/500 Tablet

Type 2 Diabetes Mellitus

Medicinal Benefits of Vilglipt-M 50/500 Tablet

METFORMIN+VILDAGLIPTIN helps your pancreas to produce more insulin, make effective utilization of insulin, and decreases excess of sugar that your liver makes. It helps in controlling the rise of blood sugar level in your body after a meal. METFORMIN+VILDAGLIPTIN plays a vital role in controlling blood sugar levels and prevents serious complications of diabetes like eyesight loss (retinopathy), kidney (nephropathy), nerve damage (neuropathy), diabetic foot ulcer and delayed wound healing.

Directions for Use

METFORMIN+VILDAGLIPTIN should not be used unless prescribed by a doctor. Always take METFORMIN+VILDAGLIPTIN exactly as your doctor told you. Your doctor will advise you how often you take your tablets on the basis of your medical condition. Swallow the tablet with a full glass of water.

Side Effects of Vilglipt-M 50/500 Tablet

Every medicine has some sort of side effects. In the beginning days of the treatment with METFORMIN+VILDAGLIPTIN, you may suffer from low blood sugar, nausea, headache, shaking or quivering, vomiting, diarrhoea, pain in and around the stomach (abdominal pain), loss of appetite, joint pain, tiredness, constipation, swollen hands, ankle or feet (oedema). But these would be temporary and may be relieved after some time. However, if you still have discomfort speak with the doctor. Lactic acidosis (excess level of lactic acid in the blood) is a rare side effect which is serious and can lead to a life-threatening condition.

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

METFORMIN+VILDAGLIPTIN should not be used in patients with type 1 diabetes or with diabetic ketoacidosis. Some diabetic patients, while taking METFORMIN+VILDAGLIPTIN, might develop a rare but serious condition called lactic acidosis. In this condition, there is too much lactic acid accumulated in the blood that can damage the working of your liver and kidney required for the elimination of excess lactic acid from the blood. Before you start taking METFORMIN+VILDAGLIPTIN, tell your doctor if you’ve ever had pancreatitis (inflammation of the pancreas), kidney disease, and low vitamin B12 level. METFORMIN+VILDAGLIPTIN, when used with insulin, may extremely lower the blood sugar level leading to hypoglycaemia condition, which can be fatal. In this case, your doctor may adjust the dose by lowering the dose of insulin or METFORMIN+VILDAGLIPTIN. Prolonged intake of METFORMIN+VILDAGLIPTIN may lower your thyroid-stimulating hormone (TSH); hence, an annual check-up of TSH is recommended. In rare cases, you may also develop a serious skin reaction known as bullous pemphigoid that requires immediate medical attention. Tell your doctor if you are going to have a diagnostic test with an injection of dye or X-ray contrast agent. The use of METFORMIN+VILDAGLIPTIN should be stopped for a short time before having an X-ray procedure.

Drug Interactions

Drug-Drug Interaction:

METFORMIN+VILDAGLIPTIN interacts with pain killers (aspirin, ibuprofen, and celecoxib), high blood pressure-lowering pills (nifedipine, captopril, enalapril, lisinopril), thyroid hormones (thyroxine), antacid (cimetidine) or certain medicines affecting the nervous system.

Drug-Disease Interaction:

People affected with heart diseases (like congestive heart failure and myocardial infarction), vitamin B12 deficiency, and alcoholism should avoid intake of METFORMIN+VILDAGLIPTIN.

Safety Advice

ALCOHOL

• It is best to avoid alcohol while taking medication.

PREGNANCY

• Please consult your doctor for advice before using METFORMIN+VILDAGLIPTIN.

BREAST FEEDING

• Please consult your doctor for advice before using METFORMIN+VILDAGLIPTIN.

DRIVING

• Drive only if you are physically stable and mentally focussed, If you experience drowsiness after taking these medications you should not drive or operate any machinery or vehicles.

LIVER

• If u have or had history or evidence of any liver-related diseases, please consult the doctor before taking the medicine.

KIDNEY

• If u have or had history or evidence of any kidney-related diseases, please consult the doctor before taking the medicine.